跳至主要内容
临床试验/NCT06441786
NCT06441786招募中不适用

A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism: Feasibility, Acceptability and Effect in a Clinical Open Trial

Uppsala University2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2024年8月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
36
试验地点
2
主要终点
Revised Children's Anxiety and Depression Scale (RCADS)

研究概览

简要总结

The goal of this open clinical trial is to try out and evaluate a group metacognitive treatment protocol, for adolescents aged 15-18 years of age with anxiety and/or depression and an autism diagnosis.

The main questions it aims to answer are:

  1. How does the recruitment to the study work and what is the retention rate?

  2. What is the level of participant compliance?

  3. Is the treatment adherence satisfactory, are there any practical problems with treatment delivery?

  4. Are the outcome measures and assessment procedures feasible?

  5. Do the participants accept the treatment, are there any reports of adverse effects?

  6. What are the preliminary effects of the treatment regarding

  7. Symptoms of anxiety and/or depression

  8. Quality of life

  9. Functional impairment

  10. Subjective level of stress

  11. Central metacognitive processes

  12. Are changes in metacognitive processes related to changes in anxiety and depression?

The participants will partake in metacognitive group treatment of 10 sessions following an initial screening.

详细描述

Participants in the study are youth (15 to 18 years of age) seeking help for anxiety and depression within child and youth psychiatry. There will a consecutive inclusion to form 6 treatment groups with 6 persons in each. The groups will meet once every week. Assessments will take place at pre- and post-treatment as well as at 6-month follow-up. Some metacognitive processes will also be monitored at each group session. The therapists have undergone a specialist training in metacognitive therapy and are experienced in using the methods. The main focus of the study is on feasibility, acceptability and preliminary effects of the treatment. These will be analyzed with paired sample t-test on primary and secondary outcomes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age of 15 to 18 years
  • Seeking medical care PRIMA psychiatric clinic for children and youth in Stockholm
  • Diagnoses of anxiety disorder or depression as well as autism established in a clinical interview
  • Mastering the Swedish language enough to take part of the treatment
  • Willingness/ability to participate after receiving information about what participation entails

排除标准

  • Assessed to meet one of the following diagnoses: Bipolar syndrome, alcohol use syndrome, substance use syndromes, psychotic symptoms and affective syndromes with psychotic symptoms and antisocial personality disorder.
  • Assessed to have a high suicide risk.
  • Assessed to have extensive self-harm behavior or moderate to high risk of such.
  • Participating in other psychological treatment or about to start such treatment during the time interval of the study.
  • Has not had stable medication in the last month or is planning a deposit/medication adjustment during the time interval of the study.

结局指标

主要结局

Revised Children's Anxiety and Depression Scale (RCADS)

时间窗: Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up

A self-report that measures symptoms of anxiety and depression.

次要结局

  • Brunnsviken Brief Quality of life questionnaire (BBQ)(Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up)
  • Metacognitions Questionnaire - 30 items version (MCQ-30)(Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up)
  • Cognitive Attentional Syndrome Scale (CAS-1)(Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up)
  • Child Sheehan Disability Scale (CSDS)(Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up)
  • Perceived Stress Scale 10 (PSS-10)(Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up.)
  • Brunnsviken Brief Quality of life questionnaire (BBQ)(Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up)
  • Metacognitions Questionnaire - 30 items version (MCQ-30)(Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up)
  • Cognitive Attentional Syndrome Scale (CAS-1)(Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up)
  • Child Sheehan Disability Scale (CSDS)(Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up)
  • Perceived Stress Scale 10 (PSS-10)(Change from pre intervention to treatment completion at 10 weeks and at a 6 month follow-up.)

研究者

发起方
Uppsala University
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验